Summary
Mycelial growth attracts academic and commercial interest because of its ability to upcycle agricultural and industrial wastes into economical and environmentally sustainable composite materials using a natural, low‐energy manufacturing process able to sequester carbon. This study aims to characterise the effect of varying ratios of high silica agricultural and industrial wastes on the flammability of mycelium composites, relative to typical synthetic construction materials. The results reveal that mycelium composites are safer than the traditional construction materials considered, producing much lower average and peak heat release rates and longer time to flashover. They also release significantly less smoke and CO2, although CO production fluctuated. Rice hulls yielded significant char and silica ash which improved fire performance, but composites containing glass fines exhibited the best fire performance because of their significantly higher silica concentrations and low combustible material content. Higher concentrations of glass fines increased volume‐specific cost but reduced mass‐specific and density‐specific costs. The findings of this study show that mycelium composites are a very economical alternative to highly flammable petroleum‐derived and natural gas‐derived synthetic polymers and engineered woods for applications including insulation, furniture, and panelling.
Type 2 Diabetes Mellitus has reached epidemic proportions as a result of over-nutrition and increasingly sedentary lifestyles. Current therapies, although effective, are not without limitations. These limitations, the alarming increase in the prevalence of diabetes, and the soaring cost of managing diabetes and its complications underscores an urgent need for safer, more efficient and affordable alternative treatments. Over 1200 plant species are reported in ethnomedicine for treating diabetes and these represents an important and promising source for the identification of novel antidiabetic compounds. Evaluating medicinal plants for desirable bioactivity goes hand-in-hand with methods in analytical biochemistry for separating and identifying lead compounds. This review aims to provide a comprehensive summary of current methods used in antidiabetic plant research to form a useful resource for researchers beginning in the field. The review summarises the current understanding of blood glucose regulation and the general mechanisms of action of current antidiabetic medications, and combines knowledge on common experimental approaches for screening plant extracts for antidiabetic activity and currently available analytical methods and technologies for the separation and identification of bioactive natural products. Common in vivo animal models, in vitro models, in silico methods and biochemical assays used for testing the antidiabetic effects of plants are discussed with a particular emphasis on in vitro methods such as cell-based bioassays for screening insulin secretagogues and insulinomimetics. Enzyme inhibition assays and molecular docking are also highlighted. The role of metabolomics, metabolite profiling, and dereplication of data for the high-throughput discovery of novel antidiabetic agents is reviewed. Finally, this review also summarises sample preparation techniques such as liquid–liquid extraction, solid phase extraction, and supercritical fluid extraction, and the critical function of nuclear magnetic resonance and high resolution liquid chromatography–mass spectrometry for the dereplication, putative identification and structure elucidation of natural compounds from evidence-based medicinal plants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.